Clinical Research
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2007; 13(29): 3948-3955
Published online Aug 7, 2007. doi: 10.3748/wjg.v13.i29.3948
Table 1 Demographics and clinical outcome of patients according to Bismuth type
Bismuth IIBismuth IIIBismuth IVP value
Number of patients214766
Age (yr)168.9 ± 2.467.5 ± 1.466.6 ± 1.30.66
Sex (M:F)16:531:1646:200.74
Serum bilirubin (mg/dL)19.55 ± 1.6614.06 ± 1.2712.69 ± 0.930.10
ERBD:EPTBD:IPTBD6:8:712:23:1216:35:150.74
Palliation of cholestasis21 (100%)43 (91.5%)7 (88%)0.30
Patency (d)1103 ± 1798 ± 12113 ± 150.85
Patency (d)292 (32-152)65 (35-95)81 (55-107)
Procedure related cholangitis5 (23.8%)12 (25.5%)12 (18.2%)0.58
Procedure related pancreatitis0 (0%)2 (4.3%)0 (0%)0.15
Procedure related bleeding1 (4.8%)5 (10.6%)6 (9.1%)0.79
Procedure related mortality0001.00
30-d mortality0 (0%)1 (2.1 %)1 (1.5%)1.00